SRPT - Margin dodolan resik Sarepta

Sarepta - logo grafis emiten SRPT

The application of AI in DNA modeling is accelerating drug development, which is driving volatility for Sarepta Therapeutics, Inc. (SRPT). Actual sales margins help filter out speculation, with the current metric standing at -5.90. Leadership in RNA therapy and large-scale investments in gene editing provide a foundation of stability. Doug Ingram's professional management is successfully navigating regulatory hurdles and effectively commercializing innovative products.

Margin bathi resik Sarepta Corp (SRPT): kanggo periode 04.07.2022 - 20.11.2026

SRPT (Sarepta Therapeutics, Inc.): rincian analitis lan laporan miturut indikator

- nilai pasar lan prakiraan target analis:
Pambiji fundamental perusahaan:Sarepta Therapeutics - SRPT
Produk dadi Sarepta Corp

To protect capital amid volatility, it is essential to track net profitability, which determines the portion of profit from every dollar of revenue after all expenses are deducted. By analyzing the company's sales margins, an investor assesses business efficiency, which for Sarepta Therapeutics, Inc. (SRPT) is highlighted by monopoly pricing power over unique gene therapies, allowing the company to maintain high returns due to a lack of market alternatives.

Pesaing Sarepta Therapeutics, Inc. (SRPT)

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|Margin resik Twist Bioscience|TXG (10x Genomics) - Rentabilitas dodolan miturut bathi resik|Intellia Therapeutics, Inc. (NTLA) - Margin dodolan resik|Margin resik Stoke Therapeutics Inc|BLFS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik WVE (Wave Life Sciences Corp)|Margin dodolan perusahaan Maze Therapeutics Corp|Sionna Therapeutics Inc - Rentabilitas dodolan miturut bathi resik|PRME (primemedicine.com) - Margin bathi resik|TSHA - Margin resik|QURE (uniQure) - Rentabilitas dodolan resik|MeiraGTx Corp (MGTX) - Margin resik|Regenxbio - Tingkat bathi resik|Margin resik solidbio.com|Margin resik ocugen.com OCGN|Margin dodolan resik PACB|Benitec - Rentabilitas dodolan resik|Margin resik Design Therapeutics DSGN|Margin dodolan resik Rocket Pharmaceuticals RCKT|Margin bathi resik 4D Molecular Corp|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX